
Tirzepatide
August 2026 drop
Tirzepatide is a synthetic dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is widely used as a reference standard in metabolic receptor-signalling and incretin-pathway research.
- 10mg / vial · $89.00
- 30mg / vial · $199.00





